The problem
Research peptides are sold into a market with uneven quality standards. Two vials with identical labels can differ substantially in purity, in actual peptide content, and in whether the contents match the stated sequence at all. Since the material is an input to research, those differences propagate directly into results. Supplier selection is therefore a methodological decision, not just a procurement one.
Criteria that carry weight
Batch-specific third-party testing
This is the single most informative criterion. Ask whether every lot is tested, whether testing is done by an independent laboratory, and whether the certificate of analysis is tied to the lot number on the vial. A supplier that tests only periodically, or that reports only in-house results, is asking you to take purity on trust.
COA availability before purchase
You should be able to review the certificate of analysis for the lot you will receive — or at minimum a representative recent lot — before committing. Reluctance here is informative.
Both purity and identity reported
HPLC purity alone is insufficient. Without mass spectrometry confirming molecular weight, a highly pure sample of the wrong compound looks excellent on paper. Insist on both.
Peptide content stated separately
Suppliers that report only purity and omit peptide content are leaving out the figure you need for accurate concentration calculations. Its absence often indicates a less rigorous analytical process.
Storage and shipping practice
Ask how material is stored before dispatch and how it is packaged for transit. Insulated packaging should be standard rather than an upcharge.
Clear research-use positioning
A legitimate research supplier states plainly that products are for laboratory research use only and makes no therapeutic or dosing claims. A supplier that implies human use, publishes dosing guidance, or markets health outcomes is operating outside the research-supply framework — and that regulatory posture tends to correlate with looser standards generally.
A practical checklist
| Question | What a good answer looks like | | --- | --- | | Is every lot tested? | Yes, before release | | Who performs the testing? | A named independent laboratory | | Can I see the COA before ordering? | Yes | | Does the COA include a chromatogram? | Yes, not just a number | | Is mass spec identity confirmed? | Yes, observed versus theoretical | | Is peptide content reported? | Yes, separately from purity | | Does the vial lot match the COA? | Yes | | Are dosing or health claims made? | No |
Warning signs
- Purity claims with no supporting analytical documentation
- The same undated COA supplied for every order
- No lot numbers on vials
- Any dosing guidance or therapeutic claim
- Prices far below the market with no explanation of how quality is maintained
- No named business address or means of contact
Evaluating a new supplier
A reasonable approach is to order a single small quantity first, review the certificate of analysis carefully against the vial received, and where you have analytical capability, verify independently. Suppliers that hold up under that scrutiny are the ones worth building a repeat relationship with. The cost of that first check is small relative to the cost of discovering a materials problem after a study is complete.
Research use only. This content is for educational and informational purposes related to scientific research. It is not medical advice and does not describe dosing or administration for human use. Products are sold for laboratory research by qualified professionals only.